Quantcast

Latest Basal cell carcinoma Stories

2014-07-14 23:00:32

LIVESTRONG and thinksport Produce Chemical Conscious Sunscreens Without Toxins Austin, Texas (PRWEB) July 14, 2014 Protect Against the Most Common Form of Cancer in the U.S. During UV Safety Month LIVESTRONG and thinksport Produce Chemical Conscious Sunscreens Without Toxins Nearly half of all cancers in the U.S. are skin cancers, with 3.5 million cases diagnosed each year. During July, UV safety month, the LIVESTRONG Foundation asks Americans to make UV safety a priority and avoid...

2014-07-03 04:21:15

Indoor tanning is becoming increasingly popular with teens and young adults. Dr. Michael Gabriel, a leading Staten Island pediatrician, discusses a recent study suggesting that indoor tanning may increase the risk of early skin cancer. BOHEMIA, N.Y., July 3, 2014 /PRNewswire-iReach/ -- Dr. Michael Gabriel or GPM Pediatrics, a Staten Island pediatrics center, comments on the article, "Tanning bed use in youth may increase risk of early skin cancer" published by Medical News Today on...

2014-07-01 23:04:24

Kevin McGuire, creator of the iTanSmart suntan app, underwent surgery this month for Basal Cell Carcimona skin cancer. His goal is to spread skin cancer awareness this summer by encouraging iTanSmart app downloads, which will lower the risk of overexposure to the sun among users. Fort Myers, FL (PRWEB) July 01, 2014 A few years ago, creator of the iTanSmart app, President of UV Technologies, LLC, Kevin McGuire, began noticing age spots on his face resulting from years of overexposure to...

2014-06-25 08:32:36

$1.5 million in proceeds to fund 2014 commencement of HPPI's clinical development program for repurposing the approved anti-fungal drug itraconazole for the treatment of cancer, initially for the treatment of Basal Cell Carcinoma Nevus Syndrome TAMPA, Fla. and SAN DIEGO, June 25, 2014 /PRNewswire/ -- HedgePath Pharmaceuticals, Inc. (OTCQB:HPPI) a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative therapeutics for patients with...

2014-06-01 08:20:47

The study met the primary endpoint with objective response rates of 41.8% and 32.5% respectively in the 200 mg and 800 mg treatment arms(1,2) EAST HANOVER, N.J., June 1, 2014 /PRNewswire/ -- Novartis announced today the results of a pivotal Phase II trial demonstrating that patients with locally advanced (laBCC) or metastatic basal cell carcinoma (mBCC) taking the investigational oral compound LDE225 (sonidegib) had marked and sustained tumor shrinkage after a median follow-up of...

2014-05-27 23:04:29

Dr. Peyman Ghasri now offers Mohs micrographic surgery to treat Squamous skin cancer, Basal Cell skin cancer, and Melanoma. Los Angeles, CA (PRWEB) May 27, 2014 Los Angeles skin cancer doctor, Dr. Peyman Ghasri, now offers Mohs micrographic surgery to treat skin cancer. More than two million Americans are diagnosed with skin cancer every year, and more skin cancers are diagnosed than breast cancers, lung cancers, colon cancers and prostate cancers combined. Mohs micrographic surgery is...

2014-05-06 08:36:28

Dr. Justin Piasecki, Washington Doctor and Mohs Surgery Expert, at Forefront of Skin Cancer GIG HARBOR, Wash., May 6, 2014 /PRNewswire/ -- Recognized as the most common cause of cancer in the United States, skin cancer accounts for approximately half of all the cancers in the country.[1] According to the Skin Cancer Foundation, more than 3.5 million cases of skin cancer are diagnosed each year, with the incidences of skin cancer outnumbering all cases of breast, colon, lung, and prostate...

2014-04-17 23:01:36

Zoll, Kranz & Borgess, LLC, (ZKB) a pharmaceutical and medical device litigation firm, is currently investigating claims of men who developed melanoma after taking the pharmaceutical drug, Viagra (sildenafil citrate), which is marketed by the US-based pharmaceutical company, Pfizer. Toledo, OH (PRWEB) April 17, 2014 Studies have suggested that sildenafil use may increase the invasiveness of melanoma cells, which may raise the possible adverse effect of melanoma. On April 7, 2014, a...

2014-03-27 08:33:21

ORPINGTON, England, March 27, 2014 /PRNewswire/ -- Michelson Diagnostics, the UK based medical device company focused on multi-beam Optical Coherence Tomography ('OCT') technology, announces positive top line results from the successfully completed multi-centre, prospective clinical trial for the diagnosis of basal cell carcinoma using VivoSight OCT. In the study, over 250 patients with clinically suspicious lesions for basal cell carcinoma were scanned...

2014-03-11 08:31:48

LOS ANGELES, March 11, 2014 /PRNewswire/ -- - Los Angeles dermatologist, Dr. Peyman Ghasri, urges patients to screen their skin and look for skin cancer symptoms. Skin cancer is the most common type of cancer in the world and accounts for about half of all cancers that are diagnosed in the United States. More than 75,000 cases of melanoma and 3.5 million cases of squamous cell and basal cell carcinomas are diagnosed every year.Being aware of skin cancer symptoms can ensure patients...


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related